Cryo-Cell International
CCEL
12 hedge funds and large institutions have $4.44M invested in Cryo-Cell International in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.81% less ownership
Funds ownership: 10.59% → 8.79% (-1.8%)
14% less funds holding
Funds holding: 14 → 12 (-2)
56% less capital invested
Capital invested by funds: $10.1M → $4.44M (-$5.69M)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$25.4K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$18.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$13.1K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$4.61K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
ISZO Capital Management
New York
|
-$1.16M |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
-$160K |
| 3 |
Millennium Management
New York
|
-$148K |
| 4 |
RP
Rowlandmiller & Partners
Atlanta,
Georgia
|
-$128K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ICM
1
ISZO Capital Management
New York
| $2.73M | -$1.16M | -125,824 | -26% |
|
|
MPWT
2
MassMutual Private Wealth & Trust
Windsor,
Connecticut
| $580K | – | – | – |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $551K | – | – | – |
|
|
SCP
4
Seizert Capital Partners
Birmingham,
Michigan
| $332K | – | – | – |
|
|
MCM
5
Maryland Capital Management
Towson,
Maryland
| $149K | – | – | – |
|
6
Bank of America
Charlotte,
North Carolina
| $46K | – | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $21K | +$25.4K | +2,753 | +21,177% |
|
|
8
Osaic Holdings
Scottsdale,
Arizona
| $15K | +$18.5K | +2,000 | New |
|
|
9
UBS Group
Zurich,
Switzerland
| $11K | +$13.1K | +1,425 | +35,625% |
|
|
10
Wells Fargo
San Francisco,
California
| $4K | +$4.61K | +500 | +2,941% |
|
11
Morgan Stanley
New York
| $3K | – | – | – |
|
|
SA
12
SFI Advisors
Montclair,
New Jersey
| $1.26K | – | – | – |
|
|
13
HighTower Advisors
Chicago,
Illinois
| – | -$160K | -13,761 | Closed |
|
|
14
Millennium Management
New York
| – | -$148K | -12,741 | Closed |
|
|
RP
15
Rowlandmiller & Partners
Atlanta,
Georgia
| – | -$128K | -11,000 | Closed |
|
CCEL Hedge Fund Activity: Q1 2022 in Review
12 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Cryo-Cell International (CCEL) for Q1 2022, worth a combined $4.44M — down 56% from $10.1M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CCEL and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 3 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $25.4K. The largest seller was ISZO Capital Management, cutting an estimated $1.16M.
- 12 institutional investors held Cryo-Cell International (CCEL) as of Q1 2022, down from 14 in Q4 2021.
- Funds reported $4.44M of Cryo-Cell International stock for Q1 2022, down 56% quarter-over-quarter.
- 1 fund opened new Cryo-Cell International positions in Q1 2022 and 3 closed out, a net change of -2 holders.
- The largest Cryo-Cell International buyer in Q1 2022 was Tower Research Capital (TRC), an estimated $25.4K added.
- The largest Cryo-Cell International seller in Q1 2022 was ISZO Capital Management, an estimated $1.16M sold.
Based on aggregated 13F filings for Q1 2022.